First established in 2005 as the UK’s first Medicines and Healthcare products Regulatory Agency (MHRA) accredited cultured stem cell facility, the unit aims to ensure that Moorfields Eye Hospital and the UCL Institute of Ophthalmology remain at the forefront of efforts to make stem cell regeneration of the eye and the restoration of vision a reality.
This work proved so beneficial that the facility was re-housed in a state-of-the-art cleanroom suite at the UCL Institute of Ophthalmology in 2011, a move made possible due to the wonderful generosity of the Sir Jules Thorn Charitable Trust and a number of other donors.
The unit focusses on the next wave of innovation in the area of stem cell research and aims to meet the increased demand for corneal and retinal stem cell therapies through the manufacture of human stem cells.
Professor Julie Daniels, who heads up the Cells for Sight team says: “The facility is vital for the development of novel sight saving treatments. This high specification suite of laboratories places us at the forefront of cell therapy research and clinical trials.”